DIAGNOS (OTCMKTS:DGNOF) Stock Price Down 1.3% – What’s Next?

DIAGNOS Inc. (OTCMKTS:DGNOF) traded down 1.3% on Wednesday . The company traded as low as $0.15 and last traded at $0.15. 28,000 shares were traded during mid-day trading, a decline of 39% from the average session volume of 46,090 shares. The stock had previously closed at $0.15.

DIAGNOS Trading Down 1.3%

The company has a debt-to-equity ratio of 1.23, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market capitalization of $15.08 million, a P/E ratio of -3.70 and a beta of 0.25. The firm has a fifty day moving average price of $0.17 and a 200-day moving average price of $0.20.

DIAGNOS (OTCMKTS:DGNOF) last posted its quarterly earnings results on Wednesday, May 28th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The company had revenue of $0.01 million during the quarter, compared to the consensus estimate of $0.09 million.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.